Intralesional alpha 2b recombinant interferon for basal cell carcinomas.
Boneschi
V
V
Second Department of Dermatology, University of Milan, Italy.
Brambilla
L
L
Chiappino
G
G
Mozzanica
N
N
Finzi
A F
AF
D000368:Aged; D000369:Aged, 80 and over; D002280:Basal Cell Carcinoma / Q000628:therapy*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000628:therapy*
D007370:Interferon Type I; D011994:Recombinant Proteins